These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28434352)

  • 1. The challenging histological diagnosis of transthyretin (ATTR) amyloidosis.
    Charkhkar E; Westermark P
    Amyloid; 2017 Mar; 24(sup1):130-131. PubMed ID: 28434352
    [No Abstract]   [Full Text] [Related]  

  • 2. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.
    Schmidt M; Wiese S; Adak V; Engler J; Agarwal S; Fritz G; Westermark P; Zacharias M; Fändrich M
    Nat Commun; 2019 Nov; 10(1):5008. PubMed ID: 31676763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.
    Sumi-Akamaru H; Eto M; Yamauchi A; Uehara T; Kakuda K; Obayashi K; Kato S; Naka T; Mochizuki H
    Neuropathology; 2018 Feb; 38(1):11-21. PubMed ID: 28960480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
    Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
    Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients.
    Nakagawa M; Sekijima Y; Tojo K; Ikeda S
    Amyloid; 2013 Jun; 20(2):138-40. PubMed ID: 23638696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
    Bergström J; Gustavsson A; Hellman U; Sletten K; Murphy CL; Weiss DT; Solomon A; Olofsson BO; Westermark P
    J Pathol; 2005 Jun; 206(2):224-32. PubMed ID: 15810051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant deposition of wild type transthyretin-derived amyloid in the gastrointestinal tract of aged individuals.
    Ikeda S; Tojo K; Suzuki-Tsuchiya A; Akamatu T; Hashimoto T; Higuchi K
    Amyloid; 2009; 16(3):174-7. PubMed ID: 19626481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies.
    Jamet MP; Gnemmi V; Hachulla É; Dhaenens CM; Bouchindhomme B; Delattre C; Glowacki F; Hatron PY; Lacour A; Lamblin N; Launay D; Leleu X; Guiochon-Mantel A; Valleix S; Maurage CA; Copin MC; Buob D
    Am J Surg Pathol; 2015 Aug; 39(8):1035-44. PubMed ID: 25828388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of transthyretin aggregation and toxicity.
    Gasperini RJ; Klaver DW; Hou X; Aguilar MI; Small DH
    Subcell Biochem; 2012; 65():211-24. PubMed ID: 23225005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
    Koike H; Yasuda T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sobue G; Katsuno M
    Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203
    [No Abstract]   [Full Text] [Related]  

  • 14. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
    Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
    Ferreira N; Gonçalves NP; Saraiva MJ; Almeida MR
    Sci Rep; 2016 May; 6():26623. PubMed ID: 27197872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.
    Gillmore JD; Maurer MS; Falk RH; Merlini G; Damy T; Dispenzieri A; Wechalekar AD; Berk JL; Quarta CC; Grogan M; Lachmann HJ; Bokhari S; Castano A; Dorbala S; Johnson GB; Glaudemans AW; Rezk T; Fontana M; Palladini G; Milani P; Guidalotti PL; Flatman K; Lane T; Vonberg FW; Whelan CJ; Moon JC; Ruberg FL; Miller EJ; Hutt DF; Hazenberg BP; Rapezzi C; Hawkins PN
    Circulation; 2016 Jun; 133(24):2404-12. PubMed ID: 27143678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transthyretin-derived amyloid (ATTR) and sarcoidosis: Does ATTR deposition cause a granulomatous inflammatory response in older adults with sarcoidosis?
    Ichimata S; Hata Y; Nomoto K; Nishida N
    Cardiovasc Pathol; 2024; 70():107624. PubMed ID: 38412903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of blood-nerve barriers in hereditary transthyretin (ATTR) amyloidosis.
    Koike H; Ikeda S; Takahashi M; Kawagashira Y; Iijima M; Misumi Y; Ando Y; Ikeda SI; Katsuno M; Sobue G
    Amyloid; 2017 Mar; 24(sup1):89-90. PubMed ID: 28434331
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.
    Butler JS; Chan A; Costelha S; Fishman S; Willoughby JL; Borland TD; Milstein S; Foster DJ; Gonçalves P; Chen Q; Qin J; Bettencourt BR; Sah DW; Alvarez R; Rajeev KG; Manoharan M; Fitzgerald K; Meyers RE; Nochur SV; Saraiva MJ; Zimmermann TS
    Amyloid; 2016 Jun; 23(2):109-18. PubMed ID: 27033334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial wild-type transthyretin cardiomyopathy.
    Benson MD; Berk JL; Connors LH; Dasgupta NR
    Amyloid; 2017 Mar; 24(sup1):91-92. PubMed ID: 28434303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.